Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BNGO has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
BNGO stock price ended at $3.26 on Tuesday, after losing-7.91%
The Bionano Genomics Inc stock price decreased by -7.91% on the last trading day (17 Jun 2025), dropping from 3.5 to 3.26. Throughout the last trading session, the stock experienced a fluctuation of 8.27% , ranging from a day low of $3.25 to a day high of 3.5188. The price has declined in 5 of the last 10 days, resulting in a total change of -11.65% during this period. On the last day, trading volume increase by 379.00 shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 115.46K shares were traded, amounting to approximately 387.05K.
BNGO Technical Signals
BNGO(Bionano Genomics Inc Corp) has 5 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-05-22. The total price change during this trend is -13.53%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of BNGO over the last 5 trading days is 280.22K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
BNGO Moving Average Analysis
Bionano Genomics Inc's overall moving average trend leans more bearish as of Wednesday, June 18, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $3.8845355999999995, and $4.0886. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $3.2242644, and $3.0202. A break-down below any of these levels will issue sell signals.
BNGO Short Selling Analysis
The short sale ratio of Bionano Genomics Inc(BNGO) as of 16 Jun 2025 is 17.91%, dropping from last trading day. With decreasing price from 3.65 to 3.54. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
4
Buy
5
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
12.964
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-396.915
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
2.778
Bullish
Williams %R (14 days)
WILLR_14 < -80
-98.273
Bullish
Ultimate Oscillator (7, 14, 28)
UO_7_14_28 < 30
27.882
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.188
Bearish
Momentum (10 days)
MOM_10 < 0
-0.43
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.0868
Bearish
Closing price
close < fibonacci_S1
3.26
Bearish
BNGO Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Bionano Genomics Inc(BNGO), our algorithm predicts BNGO's 1-month price at $4.22, with an 15.69%upwardshift. Using a similarity score up to 90.14%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Bionano Genomics Inc (BNGO.O) stock, as of Sunday, June 15, 2025 , forecasts a 15.69% change over the next month, based on its high correlation with LITB.N stock patterns. The similarity between their price movements over the analyzed periods is 90.14%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
BNGO
No Data
LITB
Up: 15.69%Similarity: 90.14%
Name
Similarity
Up/Down
LITB.N
90.14%
+15.69%
BNGO Seasonality Analysis
Based on BNGO's historical stock price data across all years, the probability of a positive return in June is30.00%, suggesting it maynotbe an ideal month to invest in BNGO. In contrast,Novemberoffers the highest probability of positive returns at50.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Bionano Genomics Inc (BNGO.O) stock in November has the highest probability of a positive return (50.00%), while April has the lowest probability (12.50%).
Performance Seasonality
The chart shows Bionano Genomics Inc. (BNGO)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Bionano Genomics Inc (BNGO.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BNGO has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Bionano Genomics Inc (BNGO.O) stock in a year?
The radar chart shows that buying Bionano Genomics Inc (BNGO.O) stock in November has the highest probability of a positive return (50.00%), while April has the lowest probability (12.50%).
How has Bionano Genomics Inc. (BNGO)'s stock price performed over the past three years?
BNGO's stock price fell by -86.87% in 2023,decreased by -85.58% in 2024, and went down by 78.72% in 2025.
Bearish technical signals of BNGO include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0, close < fibonacci_S1.
Is BNGO a buy based on overall technical signals summary?
BNGO has 5 buy signals and 4 sell signals now. Overall the technical rating for BNGO is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BNGO.
What is the trend of Bionano Genomics Inc (BNGO)'s moving average?
Bionano Genomics Inc's overall moving average trend leans more bearish as of June 18 2025, with 4 negative signals and 0 positive signal.
What is price prediction for BNGO stock next month?
The price prediction chart for Bionano Genomics Inc (BNGO.O) stock, as of June 15 2025, forecasts a 15.69% change over the next month, based on its high correlation with LITB stock patterns. The similarity between their price movements over the analyzed periods is 90.14%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for BNGO Stock?
BNGO stock is expected to trade between $3.50 and $4.50 in 2025. The stock shows signs of stabilization with improved gross margins and cost-cutting measures, despite revenue declines, supported by strategic initiatives and potential technical indicator buy signals.
What is price prediction 2030 for BNGO Stock?
BNGO stock could reach **$15-$20 by 2030** if the company successfully executes its strategic pivot and sees strong adoption of its OGM products. The stock may trade at **$5-$8** if growth is hindered by global trade tensions and execution challenges. Current improvements in gross margin and cost-cutting efforts provide a foundation for potential long-term growth.